Inventor · disambiguated record
Ute Schaeper
Also filed as: SCHAEPER UTE
3 granted patents·8 pending applications·6 citations·filing 2014–2024
57Inventor score
Files withSILENCE THERAPEUTICS GMBH7UNIV BERN3ASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE1
Top patents by PatentIndex Score
11 records- 0190US11174483B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Nov 16, 2021·6 cites·19 claims
- 0270US2025025488A1Nucleic acids for inhibiting expression of tmprss6 and iron chelatorsSILENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0363US11820971B2Nucleic acids for inhibiting expression of PROS1 in a cellUNIV BERN·Filed 2022·Granted Nov 21, 2023·0 cites·19 claims
- 0462US2022025377A1Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 0559US12076335B2Nucleic acids for inhibiting expression of TMPRSS6 and iron chelatorsSILENCE THERAPEUTICS GMBH·Filed 2019·Granted Sep 3, 2024·0 cites·12 claims
- 0655US2022135974A1Nucleic acids for inhibiting expression of pros1 in a cellUNIV BERN·Filed 2021·Application pending·0 cites
- 0754US2024240187A1Sirna targeting tmprss6 for the treatment of myeloproliferative disordersSILENCE THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 0850US2016303047A1Means for lung specific deliverySILENCE THERAPEUTICS GMBH·Filed 2014·Application pending·0 cites
- 0946US2019038557A1Means for lung specific deliverySILENCE THERAPEUTICS GMBH·Filed 2018·Application pending·0 cites
- 1044US2022243202A1Nucleic acids for inhibiting expression of pros1 in a cellUNIV BERN·Filed 2020·Application pending·0 cites
- 1144US2024229041A2Nucleic acids for inhibiting expression of cnnm4 in a cellASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ute Schaeper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →